Achieving optimal blood sugar levels often requires a multifaceted approach, especially when diet, exercise, and standard single or dual therapies are not enough. SITACRED-DM FORTE is a high-potency, triple-drug combination therapy designed to simplify complex diabetes management. By combining three advanced antidiabetic agents—Dapagliflozin (10mg), Sitagliptin (100mg), and Metformin (1000mg) Sustained Release—this tablet offers a powerful, all-in-one solution for adults with Type 2 Diabetes Mellitus.
What is SITACRED-DM FORTE?
SITACRED-DM FORTE is a Fixed-Dose Combination (FDC) medication that brings together three different classes of drugs to target high blood sugar from multiple biological angles. The “Forte” designation highlights its robust strength, featuring a 1000mg Sustained Release (SR) dose of Metformin to ensure steady, long-lasting glucose management throughout the day.
Product Composition:
- Dapagliflozin (10mg): An SGLT2 inhibitor that helps the kidneys remove excess sugar through urine.
- Sitagliptin (100mg): A DPP-4 inhibitor that boosts natural hormones to increase insulin release and lower glucagon.
- Metformin SR (1000mg): A biguanide in a sustained-release format that reduces sugar production in the liver and improves insulin sensitivity.
How SITACRED-DM FORTE Works
The effectiveness of this triple therapy lies in its Complementary Mechanism of Action:
- Kidney Support (Dapagliflozin): It blocks the reabsorption of glucose in the kidneys, allowing excess sugar to be naturally flushed out of the body.
- Pancreas & Liver Regulation (Sitagliptin): It increases the levels of “incretins,” which signal the pancreas to produce more insulin after meals while telling the liver to stop making unnecessary sugar.
- Metabolic Efficiency (Metformin): It makes your body more sensitive to the insulin it already produces and slows down the absorption of sugar from the intestines.
Key Uses of SITACRED-DM FORTE
This advanced formula is primarily prescribed for:
- Intensive Glycemic Control: For adults whose Type 2 Diabetes is inadequately controlled by dual therapy (e.g., Metformin plus one other agent).
- HbA1c Management: Effectively lowering long-term average blood sugar (HbA1c) levels more significantly than dual combinations.
- Fasting & Post-Meal Support: Providing a stable reduction in both morning (fasting) and after-meal (post-prandial) glucose spikes.
Benefits of SITACRED-DM FORTE
1. Superior Blood Sugar Reduction
Studies have shown that triple FDC therapy provides significantly better glycemic control compared to dual combinations, helping more patients reach their target HbA1c of less than 7%.
2. Weight Management Support
Dapagliflozin helps the body lose calories by excreting excess sugar in the urine, which can lead to modest weight loss—a major benefit for overweight diabetic patients.
3. Heart and Kidney Protection
The inclusion of Dapagliflozin offers extra-glycemic benefits, including lowering the risk of hospitalization for heart failure and providing protective effects for the kidneys.
4. Sustained-Release Technology
The 1000mg SR Metformin ensures that the medication is released slowly and consistently. This provides 24-hour coverage and is generally gentler on the stomach compared to immediate-release versions.
5. Improved Patient Compliance
Managing diabetes often involves taking several different pills. SITACRED-DM FORTE simplifies this by combining three essential medications into a single, once-daily tablet, making it much easier to stay on track with your treatment.
Why Choose Novalab Cardiac?
At Novalab Cardiac, we focus on delivering life-enhancing pharmaceutical solutions. SITACRED-DM FORTE is manufactured under strict quality standards to ensure you receive a pure and potent product that helps prevent serious diabetes complications like nerve damage, vision loss, and cardiovascular issues.
Achieve better control and a healthier future with SITACRED-DM FORTE.
